Moreover, while other tumor cells are more or less susceptible to anticancer therapy, CSCs seem more resistant and involved in progression to hormone-receptor negative and chemotherapy-resistant tumor cells [165, 167–170]. The gene discussed is NR4A1; the disease is neoplasm.